Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus

Dolutegravir-associated hyperglycaemia in patients with HIV

(2020) Mohammed Lamorde et al.   Lancet HIV

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

(2020) Kassem Bourgi et al.   Journal of the International AIDS Society

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

(2020) Michael S. Saag et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy

(2019) Kassem Bourgi et al.   CLINICAL INFECTIOUS DISEASES

340. Prevalence of Type II Diabetes Mellitus Among Patients Living with HIV in the United States

(2019) Morgan Birabaharan et al.   Open Forum Infectious Diseases

345. Acute Onset Diabetic Ketoacidosis/Hyperosmolar Hyperglycemic State in Patients Taking Integrase Strand Transfer Inhibitors

(2019) Afua Duker Ntem-Mensah et al.   Open Forum Infectious Diseases

Brief Report

(2017) Jamison Norwood et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Dolutegravir-induced hyperglycaemia in a patient living with HIV

(2017) Milena McLaughlin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Integrase strand transfer inhibitor-associated diabetes mellitus: A case report

(2016) Peter S Fong et al.   INTERNATIONAL JOURNAL OF STD & AIDS